The blood platelets have many of the characteristics of living cells including an active metabolism. As in other cells, the concentration of potassium within platelets is high in comparison to that of extracellular fluid and-is similar to that of red blood cells (1) . ATP also is present in high concentration within platelets (2) and is considered to provide the energy necessary for clot retraction, a process that requires metabolically active platelets (3) . Unlike other cells, platelets are uniquely susceptible to the effects of thrombin, a proteolytic enzyme formed during clotting of blood. During coagulation, the platelets undergo a complex series of morphologic and biochemical changes (4) , and there is a decrease in the concentration of some of the constituents of platelets, including potassium (1) and ATP (5) . The present studies were designed to investigate some of the factors that influence changes in potassium and ATP within platelets.
Methods
All glassware with which platelets had contact was coated with silicone.' Blood was drawn from normal human donors through 15-gauge, uncoated, disposable metal needles attached to plastic tubing and was collected in tubes containing an aqueous solution of the disodium * Submitted for publication February 26, 1964; accepted July 7, 1964. This investigation was carried out under contract AT (30-1) 1208 between the Atomic Energy Commission and Johns Hopkins University and was supported in part by research grants HE-01601 and A-1775 from the National Heart Institute and a research career program award (AM-K3-3779) and a graduate training grant (Tl 5260) from the National Institute of Arthritis and Metabolic Diseases of the U. S. Public Health Service.
Presented in part at the meeting of the Federation of American Societies for Experimental Biology in April 1963 and abstracted in Fed. Proc. 1963, 22, 505. t Postdoctoral fellow, U. S. Public Health Service. 1 General Electric silicone SC-87, Dri-Film. salt of EDTA as an anticoagulant (1 part EDTA: 9 parts blood). The final concentration of EDTA in blood was 0.005 M. Platelet-rich plasma was obtained by differential centrifugation (6) . Unless specified otherwise, platelets from 3-ml portions of platelet-rich plasma were sedimented (6) and washed twice with and finally resuspended in 1.8 ml of Tris-buffered saline, pH 7.5 (6) , containing potassium chloride (0.004 M), glucose (0.0055 M), and EDTA (0.0013 M). The washing procedures were performed at 40 C and required approximately 30 minutes. Platelet counts were performed on these suspensions by the method of Brecher and Cronkite (7) . The final concentration of platelets was approximately 250,000 per mm'. The washed platelets then were incubated without agitation at 370 C under various experimental conditions. After incubation, the platelets to be analyzed for potassium and ATP were washed once with Tris-buffered saline containing EDTA but no potassium or glucose. Those to be analyzed for sodium were washed once with Tris-buffered potassium chloride (0.155 M) containing EDTA. The final washing procedure was performed at 40 C and required approximately 10 minutes. The platelets then were sedimented by centrifugation at 22,000 g for 5 minutes at 40 C and lysed in 3 ml of a 3% solution of trichloroacetic acid. Potassium and sodium in the lysates were measured by use of a flame photometer employing an internal lithium standard. ATP, in most experiments, was measured after fractionation of the lysate on a Dowex-1 anion exchange column by use of a Beckman model DU spectrophotometer reading at 260 mg (8) . In other experiments ATP was measured either by the firefly luminescence method or enzymatically in neutralized perchloric acid lysates of platelets by use of hexokinase and glucose-6-phosphate dehydrogenase (G-6-PD) (9) . Radioactive potassium (K42)3 was measured by use of a well-scintillation detector. Thrombin 4 and trypsin 5 Figure 1 . Platelets that had lost potassium during incubation in potassium-free buffer for 2 hours did not lose additional potassium after addition of thrombin (100 U per ml). Studies of the release of potassium by various agents, therefore, were performed using platelets that were washed with and incubated in Tris-buffered saline containing EDTA, glucose, and potassium.
\Vashed platelets incubated with thrombin contained 35% less potassium than did controls. The decrease was maximal after 10 minutes and was the same between concentrations of platelets from 100,000 to 500,000 per mm3 and concentrations of thrombin from 1.0 to 100 U per ml. Thrombin in the presence of calcium ions produced a greater net loss (64%o) of potassium from platelets than did thrombin alone, and the loss again was maximal after 10 minutes. Platelets incubated with calcium chloride in the absence of thrombin were not depleted of potassium. Results of these studies are summarized in Table  I . In six of the experiments, platelets incubated with thrombin (100 U per ml) contained, on an average, 27%o more sodium than did controls, but the sodium content of platelets incubated with thrombin and calcium chloride (0.005 M) was the same as that of controls. The sodium content In five experiments, twice washed human red blood cells (50,000 to 600,000 per mm3) incubated with thrombin (100 U per ml) or thrombin and calcium chloride (0.005 M) under the conditions of these experiments showed no change in content of potassium.
Platelets incubated with thrombin and calcium chloride tend to aggregate and cannot be counted accurately. To determine whether the decrease in concentration of potassium was due to a loss of platelets, the procedure was modified in two experiments. The platelets were lysed in 0.02 N HCl rather than in trichloroacetic acid after the period of incubation and washing. The concentrations of potassium and protein of the lysates were measured, and the concentration of potassium was related to that of protein. Platelets incubated with thrombin contained 457O less potassium per mg of platelet protein than did controls, and those incubated with thrombin and calcium chloride contained 66% less potassium.
Trypsin or trypsin and calcium chloride produced a net loss of potassium from platelets that was comparable to that produced by thrombin or thrombin and calcium chloride. Plasmin, in contrast, did not alter the potassium content of platelets even after incubation for periods up to 60 minutes. Sodium fluoride (NaF) produced a net loss of 50% of potassium from platelets; and sodium fluoride in the presence of thrombin, a net loss of 67%o of the potassium. The addition of calcium chloride did not enhance the change of potassium in platelets produced by sodium fluoride and thrombin. Results of these experiments are summarized in Table I .
Uptake of radioactive K42 by platelets and the effect of thrombin. In six experiments, twice washed platelets from 3-ml portions of plateletrich plasma were incubated at 370 C in Trisbuffered saline containing radioactive potassium (K42) in addition to stable potassium, glucose, and EDTA. The concentration of stable potassium in the buffer differed with each experiment in order to maintain -the amount of radioactivity (counts per minute) sufficiently high for accurate counting. This variation did not influence the results. After varying periods of time the platelets were separated from the buffer, washed once, and the radioactivity as well as the total potassium of the buffer and of lysates of the platelets was measured. The K42 in the platelets reached an apparent maximum within 60 minutes (Figure 2) , and the average specific activity [K (counts per minute)/total K (mmoles)] of the potassium in the platelets was 64% of the specific activity in the buffer (Table II) In contrast, the reduced amount of potassium present in platelets exposed to thrombin or thrombin and calcium chloride was completely equilibrated with the potassium in the media in 30 minutes (i.e., the specific activity of K142 in platelets incubated with thrombin or thrombin and calcium chloride was approximately the same as that in the buffer). The accumulation of radioactive potassium (counts per minute) in platelets exposed to thrombin was the same as that of controls, but the total content of potassium was lower and the specific activity correspondingly higher in thrombin-treated platelets. These experiments are summarized in Table II The clot retraction activity of platelets that had been depleted of ATP by incubation with thrombin was measured in seven ot these experi-ments. Portions (0.5-ml) of the suspensions of platelets that had been incubated with thrombin or thrombin and calcium chloride as described in the preceding paragraph were added to 0.5 ml of EDTA platelet-free plasma. The plasma was clotted by addition of calcium chloride (0.2 ml, 0.05 M) and thrombin (0.1 ml, 100 U) and incubated for 2 hours at 370 C in silicone-coated tubes. In each instance, clots containing platelets (final concentration, approximately 125,000 per mm3) that had been depleted of 60 to 90% of their ATP by incubation with thrombin retracted maximally, and the degree of retraction was comparable to that of clots containing control platelets.
The ability of thrombin-treated platelets to support clot retraction also was measured semiquantitatively. In two experiments, twice washed platelets were incubated for 30 minutes with thrombin (100 U per ml) as described above. After incubation, the platelets were sedimented and resuspended in EDTA platelet-free plasma to give concentrations of platelets ranging from 30,000 to 700,000 per mm3. The plasma samples were clotted by addition of calcium chloride and thrombin and the clots incubated in silicone-coated tubes at 370 C for 2 hours. Retraction of the clots containing platelets previously incubated with thrombin was comparable to that of clots containing platelets previously incubated in buffer alone. Thrombin-treated and control platelets produced maximal retraction at concentrations of platelets > 90,000 per mm3 and partial retraction at lower concentrations of platelets. In a similar experiment, platelets incubated with thrombin were resuspended at various concentrations (45,000 to 350,000 per mm3) in platelet-free plasma prepared from blood collected with sodium citrate as an anticoagulant (1 part 3.8% sodium citrate: 9 parts blood). The plasma then clotted within 2 minutes without the subsequent addition of thrombin or calcium chloride, and the clots retracted. Retraction again was maximal at concentrations of platelets of > 90,000 per mm3 and partial at lower concentrations of platelets.
Discussion
The present studies provide further evidence of the unique susceptibility of platelets to the action of thrombin. The loss of potassium from platelets produced by thrombin apparently was not due to a general effect on all cells, since thrombin did not induce a loss of potassium from red blood cells. The mechanism of action of thrombin on platelets is not completely understood but involves, at least in part, proteolysis of a clottable protein (platelet fibrinogen) that appears to be associated with the platelet membrane (6) . Platelets treated with thrombin no longer contain clottable protein (14) . It has been suggested that the release of 5-hydroxytryptamine from platelets by thrombin is due to an effect of thrombin on the platelet membrane leading either to increased permeability (15) or to expulsion (release) of intraplatelet material (15, 16) .
Our studies have shown that thrombin in the presence of divalent cation (calcium) induced a greater net loss of potassium from platelets than did thrombin alone. Divalent cations are known to influence other effects of thrombin on platelets (17) and also to affect the reaction of thrombin and plasma fibrinogen (18) . The enhanced release of potassium from platelets by thrombin in the presence of divalent cation may be due to an alteration of the reaction of thrombin with platelet fibrinogen, but other possibilities exist.
Trypsin, another proteolytic enzyme, which affects plasma fibrinogen in a manner similar to thrombin (19) and which removes clottable protein (6, 14) and releases 5-hydroxytryptamine from platelets (15, 16) , caused a loss~o f potassium from platelets comparable to that produced by thrombin. In contrast, plasmin, which splits different bonds in plasma fibrinogen than does thrombin (20) and does not release 5-hydroxytryptamine from platelets (14), did not affect the concentration of potassium in platelets. Recent studies have shown that the concentration of plasmin employed in our studies does not remove clottable protein from platelets (21) .
Sodium fluoride, a potent inhibitor of glycolytic metabolism, was demonstrated in the present studies to produce a net loss of 50%o of potassium from human platelets and to augment the effect of thrombin on the loss of potassium from platelets to approximately the same degree as divalent cation. Platelets treated with fluoride, in contrast to those treated with thrombin, are not capable of supporting clot retraction (22 (3, 16, 23) . We have consistently noted a profound fall of ATP in washed platelets exposed to thrombin alone or thrombin and calcium chloride. The ATP in platelets has been reported to supply the energy necessary for clot retraction (3) . In the present studies, platelets depleted of 60 to 90% of their ATP by exposure to thrombin were capable, under appropriate conditions, of supporting clot retraction. It is possible that the small fraction of ATP remaining in platelets after exposure to thrombin was sufficient to supply the energy required for retraction. The ATP content of platelets exposed to thrombin in the presence of glucose increases transiently (3), and it is also possible that ATP was regenerated by thrombin-treated platelets that were resuspended in fresh plasma.
Summary
Washed human platelets incubated in potassiumfree buffer lost approximately 80%o of their potassium, but this loss did not occur from platelets incubated in buffer containing potassium. Thrombin induced a rapid net loss of approximately 35%o of the potassium from platelets incubated in buffer containing potassium. Calcium augmented the effect of thrombin on potassium loss from platelets to approximately 60%. These agents did not cause a net loss of potassium from human red blood cells. Trypsin was similar to thrombin in its effect on the loss of potassium from platelets, but plasmin had no effect.
Studies employing radioactive potassium (K42) revealed equilibration of one-half to two-thirds of the potassium in the platelets with that in the surrounding media in control studies but with all of the potassium remaining after treatment with thrombin. The results suggest that potassium may be distributed within two compartments in the human platelet.
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